Pages that link to "Q43586591"

The following pages link to Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. (Q43586591):

Displaying 41 items.

• Acute meningoencephalitis and meningitis due to primary HIV infection (Q24527228) (← links)
• Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort (Q28477246) (← links)
• Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection (Q28478459) (← links)
• The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies (Q30406868) (← links)
• Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection (Q30479692) (← links)
• Practice Guidelines for Evaluation of Fever in Returning Travelers and Migrants (Q31141770) (← links)
• Resisting immune exhaustion in HIV-1 infection. (Q33332291) (← links)
• Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy (Q33636301) (← links)
• Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants (Q33753695) (← links)
• HIV dynamics in seminal plasma during primary HIV infection (Q34083267) (← links)
• Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity (Q34195573) (← links)
• Identifying acute HIV infection in Rhode Island (Q34765975) (← links)
• Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy (Q34789249) (← links)
• Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals (Q34996361) (← links)
• Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8 T cells in primary HIV-1 infection (Q35020830) (← links)
• Drug interactions between antiretroviral drugs and comedicated agents (Q35072074) (← links)
• Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4 T lymphocytes. (Q35144874) (← links)
• Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia (Q35810923) (← links)
• Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group (Q36136406) (← links)
• Primary human immunodeficiency virus type 1 infection (Q36223861) (← links)
• Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort (Q36280900) (← links)
• HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs (Q36770954) (← links)
• Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells (Q37365391) (← links)
• Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001. (Q38074089) (← links)
• Genomic detection of human immunodeficiency virus (HIV) by nucleic acid amplification test in a frequent platelet donor during the pre-seroconversion period (Q39363200) (← links)
• Naturally occurring Vpr inhibitors from medicinal plants of Myanmar (Q39417142) (← links)
• Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors (Q39638662) (← links)
• Evidence for human immunodeficiency virus type 1 replication in vivo in CD14( ) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy (Q39688634) (← links)
• Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003). (Q40478218) (← links)
• Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection (Q40519226) (← links)
• Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care (Q43488729) (← links)
• Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals (Q44131292) (← links)
• Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies (Q44190546) (← links)
• Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic. (Q53587780) (← links)
• Treatment outcomes in a rural HIV clinic in South Africa: Implications for health care. (Q53762202) (← links)
• Primary HIV Infection. (Q53781581) (← links)
• Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort. (Q53885344) (← links)
• Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. (Q54247474) (← links)
• New HIV protease inhibitors for drug-resistant viruses (Q58389032) (← links)
• Cross-subtype Detection of HIV-1 capsid p24 antigen using a Sensitive Europium Nanoparticle Assay (Q58558926) (← links)
• Treatment of Primary HIV (Q77657662) (← links)